Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 11 Jan 2022 |
10 | TM-M(EXTENSION OF TIME) | 18 Jun 2024 |
11 | TM-M(EXTENSION OF TIME) | 24 Jun 2024 |
12 | Annexure -1 under rule 46 | 16 Jul 2024 |
12 | Evidence Affidavit Under Rule 46 (TOP) | 16 Jul 2024 |
13 | Annexure -1 under rule 46 | 16 Jul 2024 |
13 | Evidence Affidavit Under Rule 46 (TOP) | 16 Jul 2024 |
14 | Evidence Affidavit Under Rule 46 (TOP) | 25 Jul 2024 |
15 | Annexure -1 under rule 46 | 25 Jul 2024 |
16 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 26 Jul 2024 |
2 | Reply to Exam Report (MIS-R) | 14 Mar 2022 |
3 | Authorization Letter | 14 Oct 2022 |
4 | Documents in support of Show cause Hearing (SCH) | 17 Apr 2023 |
5 | Authorization Letter | 18 Apr 2023 |
6 | Journal Copy | 23 Jun 2023 |
7 | TM-O(NOTICE OF OPPOSITION) | 01 Aug 2023 |
8 | TM-O(NOTICE OF OPPOSITION) | 28 Aug 2023 |
9 | TM-O(NOTICE OF OPPOSITION) | 05 Sep 2023 |
1 | EXAMINATION REPORT | 13012827 | 14 Feb 2022 | |
2 | Hearing Notice (Show Cause) | 13956305 | 18 Aug 2022 | |
3 | Hearing Notice (Show Cause) | 15015471 | 27 Mar 2023 | |
4 | Tribunal Accepted Notice for : 5280692 | 15183059 | 5939263 | 02 May 2023 |
5 | Opposition Notice | 16693584 | 6364189 | 01 Dec 2023 |
6 | Opposition Notice | 16706439 | 6367782 | 02 Dec 2023 |
7 | Opposition Counter Statement | 17449650 | 6563017 | 19 Feb 2024 |
8 | Opposition Counter Statement | 17532186 | 6585229 | 26 Feb 2024 |
The application for Fibrogen was made on 11 January 2022.
The trademark applicant for Fibrogen is INTAS PHARMACEUTICALS.
Fibrogen is applied in class(es) 5.
Application for Fibrogen is on Opposed stage.
Application Id allotted to Fibrogen is 5280692.
Trademark agent or attorney for the application is Y. J. Trivedi & Co.
Fibrogen filed with the Intellectual property office as a WORD.